Form 4 filed by Kieser Brian Joseph
Kieser Brian Joseph filed this Form 4 on NXGL (NEXGEL, INC.) with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-14 02:59:13 UTC.
- Accession
- 0001493152-26-051920
- Filer
- CIK 2133654
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: NXGL · NEXGEL, INC. (CIK 1468929)
- Kieser Brian Joseph director, officer (Interim CEO), 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-10 | P bought | +133,216 | $5.5 | 133,216 | I By Sequence LifeScience, Inc. |
| Warrant to Purchase Common Stock (the "PIPE Warrant") derivative | 2026-11-10 | P bought | +133,216 | $0 | 133,216 | I By Sequence LifeScience, Inc. |
| Convertible Promissory Note (before amendment) derivative | 2026-11-10 | D returned to the issuer | +83,334 | 0 | D | |
| Convertible Promissory Note (as amended) derivative | 2026-11-10 | A granted | +181,819 | 181,819 | D | |
| Warrant to Purchase Common Stock derivative | 2026-11-10 | D returned to the issuer | +41,667 | 0 | D | |
| Existing Warrant (as amended) derivative | 2026-11-10 | A granted | +41,667 | 41,667 | D | |
| Convertible Promissory Note (before amendment) derivative | 2026-11-10 | D returned to the issuer | +458,334 | 0 | I By Sequence LifeScience, Inc. | |
| Convertible Promissory Note (as amended) derivative | 2026-11-10 | A granted | +1,000,000 | 1,000,000 | I By Sequence LifeScience, Inc. | |
| Existing Warrant (before amendment) derivative | 2026-11-10 | D returned to the issuer | +229,167 | 0 | I By Sequence LifeScience, Inc. | |
| Existing Warrant (as amended) derivative | 2026-11-10 | A granted | +229,167 | 229,167 | I By Sequence LifeScience, Inc. |